Innate immunity and monocyte-macrophage activation in atherosclerosis. - Wikidata - awgldk - TriplyDB

Innate immunity and monocyte-macrophage activation in atherosclerosis.

Innate immunity and monocyte-macrophage activation in atherosclerosis.

http://www.wikidata.org/entity/Q34980214

about

Effects of chalcone derivatives on players of the immune system PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice GPR109A and vascular inflammation "Of mice and men": arginine metabolism in macrophages Phenotypic polarization of macrophages in atherosclerosis DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages The omega-3 fatty acid docosahexaenoic acid favorably modulates the inflammatory pathways and macrophage polarization within aorta of LDLR(-/-) mice.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Immune modulation by different types of β2→1-fructans is toll-like receptor dependent LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice.Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy.CD73 Activity is Dispensable for the Polarization of M2 Macrophages.Distinct macrophage phenotype and collagen organization within the intraluminal thrombus of abdominal aortic aneurysm.RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis.Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis.TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.The utility of collaborative biobanks for cardiovascular research.Molecular pathways regulating macrophage polarization: implications for atherosclerosis.Novel immune signals and atherosclerosis.Molecular biology of atherosclerosis.HDL in innate and adaptive immunity.Role of host- and pathogen-associated lipids in directing the immune response in mycobacterial infections, with emphasis on Mycobacterium avium subsp. paratuberculosis.Advances in the pathogenesis of cardiorenal syndrome type 3.Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.Conjugated linoleic acid induces an atheroprotective macrophage MΦ2 phenotype and limits foam cell formation.Systems Approach Reveals Nuclear Factor Erythroid 2-Related Factor 2/Protein Kinase R Crosstalk in Human Cutaneous Leishmaniasis.The Role of the NLRP3 Inflammasome in Fibrosis.The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.Heart-kidney crosstalk and role of humoral signaling in critical illness Toll-like receptor activity in patients with obstructive sleep apnea.The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases.Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.An anti-CAPN5 intracellular antibody acts as an inhibitor of CAPN5-mediated neuronal degeneration.Macrophage-Specific Expression of IL-37 in Hyperlipidemic Mice Attenuates Atherosclerosis.Diacylglycerol kinase synthesized by commensal Lactobacillus reuteri diminishes protein kinase C phosphorylation and histamine-mediated signaling in the mammalian intestinal epithelium.HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.

P2860

Q26796454-270821D1-50B8-423C-AC86-A99AD9425A09 Q28255961-BDE7BA4F-F9F3-4CDD-A743-3F7CEE9F359E Q28287747-96B224EC-A1DE-4C42-985E-F9444000F12C Q28395476-125CAC71-D7BF-42E4-A847-FDC07D26F5AC Q30412717-1F1F9EB8-9F53-4461-B436-3C4077CBF804 Q33789568-C39B5F7F-5E0A-4DA0-BC98-4E77B361BB4C Q34232750-D4935A50-EDB0-4651-9CCE-DD5ECB6DA50F Q34350546-947E96D1-08DA-4D1F-B8ED-E07C45224E98 Q34827374-8BD8C5DA-CA4E-4553-A0A2-5830A81F2630 Q35390964-34A55B30-7DE2-4389-8CB4-FD5CBBDF8B88 Q35595537-568BFD5D-3B12-4731-A840-28137C3E258C Q35741497-D9C44447-91F9-4CB2-94B6-7089E809A14D Q35998243-ABB936BC-6562-4D4B-AC40-2667A9048B7B Q36055706-694EA0E8-671B-4D7D-A5DD-84004E9F2649 Q36095994-91A2F9E6-9C46-474B-B144-B0D0F80DB5CD Q36196806-8438D170-7452-4581-BEA7-B70EDC395B30 Q37104535-82A7DE36-FDC9-460A-9E09-6A1D85FE0ED6 Q37366497-5AB43965-EA20-4062-93BF-294A79337005 Q37368874-5BC5A8AE-AB1F-443A-A6C1-7A1674D44C8D Q37928825-09A40E45-824E-43A8-89EF-301726CB4E0F Q37992524-7B77214D-3935-4388-AA96-5C3873D04F10 Q38032155-54C719EF-6E03-4512-9FAD-523D4B35291C Q38125279-FD5D8EA5-2AE7-47C7-8CAD-203EB9717E7B Q38220759-36E6FF27-623B-4064-BB52-CC47A5812780 Q38243971-6FE88F40-BE5C-4BC1-A04A-471F03A16B2F Q38395507-21FFF250-F210-4657-B195-9EE29EE0AC08 Q38903993-7DAFCD84-3F20-4372-95E8-ED2EF4A24F5D Q40600319-843E2E7C-BB1F-4DC5-9329-2FE6A935168B Q41342312-168F93CE-1C6C-455B-86FF-6E8138ADF6B8 Q41673013-6F12C1F9-51DC-463E-ABC6-6A83C970E24B Q41975783-0BD7FC10-B8F3-434A-80A0-2A1AB1C905BD Q42201820-F8A59427-00F9-4AFC-A4B3-8EF4496F54F8 Q42696824-E9FAEE05-4D00-4A16-A728-B97D71EC15C3 Q45323315-62021D19-1F53-4E33-9BC1-F198726A2449 Q47104734-63D67345-A67C-4F59-AA51-19B367A5BAAD Q47119800-13FCCCD9-D67A-421A-B0F4-2B4A5D39B68E Q47136494-50170770-B5F1-404B-9A0C-FE51FAC67A9B Q47654931-71DBA422-7E34-4593-B2E3-4B960878D869 Q47879101-3B287647-B554-40D1-BAB2-E39A2E54A52C Q50045865-2324953E-6291-4C31-98CB-DBCE9001D2B0

P2860

Innate immunity and monocyte-macrophage activation in atherosclerosis.

http://www.wikidata.org/entity/Q34980214

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@ast

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@en

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@nl

type

label

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@ast

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@en

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@nl

prefLabel

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@ast

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@en

Innate immunity and monocyte-macrophage activation in atherosclerosis.

@nl

P1433

Q34980214-032A3DCA-1F10-43FD-AA17-236CD489AAFF

P1476

Q34980214-B698DCD6-5392-4014-A6EC-472F5927E503

P2093

Q34980214-0413E1DE-E6E1-4FF2-B5B5-69CCF6EC59F8

Q34980214-8663FE0C-C147-4B14-B1B5-5B3A546EDEBD

P2860

Q34980214-0317401C-F7D1-4B21-8BBC-8303DE82B9D6

Q34980214-04854109-31A5-4015-B2EA-6818E6BA6874

Q34980214-062E9C1B-F3CF-47E2-BE01-BCEBC6CE14F1

Q34980214-07349B0E-97BF-4F15-93E8-6DC4EEA1622D

Q34980214-079AE719-1FB8-4309-ABFC-CAA681EAE0DE

Q34980214-0AD00468-FACF-4187-888E-3F723EA85E32

Q34980214-0AD424DB-8C52-42C6-BDE9-AF853882AFCB

Q34980214-0BABD233-AEEA-4A50-88B9-92AE8970A8E0

Q34980214-0C0615A0-E270-479A-A255-A9C7E742009C

Q34980214-0F354754-6950-4028-A56E-E9DA8BC34009

P2888

Q34980214-0843F9B1-3B6D-4457-A7E6-A1C1CAF83679

P304

Q34980214-9D18C090-931E-4FBF-AC40-4A2F6C89C0DC

P31

Q34980214-6606B3BA-F6EB-4DB6-A78C-1A9655F88F99

P356

Q34980214-4F3E0B91-6CB9-44A9-8416-4E0898B9BD09

P478

Q34980214-DB479E26-37F8-48D7-871B-BD570EDAC682

P50

Q34980214-7E53E5F5-C6DC-4A64-94B3-84E393FDD61C

Q34980214-8BEAA71E-3BBD-4145-8A15-9355F90F2417

P577

Q34980214-B4BC1501-DB7C-407C-88C3-C74DA5FF55D5

P5875

Q34980214-81D88DBA-4743-463E-A0DB-6707C2B0B6D5

P6179

Q34980214-82474223-0A43-4F18-A1C8-6FAED16701F3

P698

Q34980214-8648DB8A-2848-4717-A456-78F7480BA941

P921

Q34980214-70097EA0-2E1F-4EB9-9E0F-1AA63FEBB47C

Q34980214-ADF6C1A7-2DE5-4056-BAF7-E9E7463C5E0F

P932

Q34980214-D9F35EA0-4CC2-4098-87CD-1EB6BE8DE4A1

P356

P1433

Journal of Inflammation

P1476

Innate immunity and monocyte-macrophage activation in atherosclerosis

@en

P2093

Alun H Davies

http://www.w3.org/2001/XMLSchema#string

Mika A Falck-Hansen

http://www.w3.org/2001/XMLSchema#string

P2860

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

Blood monocytes: development, heterogeneity, and relationship with dendritic cells

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

Unexpected protective role for Toll-like receptor 3 in the arterial wall

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Exploring the full spectrum of macrophage activation

IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype

Atherosclerosis — An Inflammatory Disease

Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings

Alternative activation of macrophages

P2888

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-9255-8-9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Shalhoub

P577

2011-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51083558

http://www.w3.org/2001/XMLSchema#string

P6179

1049976060

http://www.w3.org/2001/XMLSchema#string

P698

21526997

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3094203

http://www.w3.org/2001/XMLSchema#string